The federal government has reaffirmed its commitment to eliminating onchocerciasis, also known as river blindness, within the ...

Onchocerca volvulus -- the parasite that causes river blindness--has not been shown to affect brain function, which would be required if the parasite were also directly responsible for causing NS.

The Food and Drug Administration (FDA) has approved moxidectin for the treatment of onchocerciasis (river blindness) due to Onchocerca volvulus in patients ≥12 years of age.. Moxidectin, a ...

The Scientist's content tagged with: Onchocerca Volvulus. Despite a fierce civil war, scientists led a 14-year grassroots campaign that has eradicated a parasitic disease from northern Sudan.

In sub-Saharan Africa and parts of Latin America, there is a parasitic worm that infects about 25m people, causing serious skin diseases, epilepsy and blindness. Known as Onchocerca volvulus, it ...

Despite significant progress in eliminating river blindness, also known as onchocerciasis, around 50 million Nigerians remain at risk.

Onchocerca volvulus is transmitted to humans by blackflies that live and breed near fast-flowing rivers and streams, giving the disease the “river” part of its name.

STROMECTOL has no activity against adult Onchocerca volvulus parasites.” The FDA adds , “some topical (on the skin) forms of ivermectin are approved to treat external parasites like head lice ...

"If the children born during the treatment period test negative, we can confirm that transmission is no longer occurring in those areas” ...

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be ...